News | February 10, 2008

Medrad, Possis Medical Sign $361 Million Merger Agreement

February 11, 2008 – Medrad Inc. today said it entered into a definitive merger agreement to acquire Possis Medical Inc., which in combination will offer a broader, more comprehensive suite of products to the cardiovascular intervention field.

The cash tender offer is for $19.50 per share, or a total equity value of approximately $361 million. The offer price represents a premium of approximately 39 percent over Possis Medical’s average closing price for the 30 days prior to Feb. 8, 2008. The Possis Medical Board of Directors unanimously approved the transaction and will recommend the offer to its shareholders. The parties agreed to commence within the next 10 business days followed by a merger.

Medrad is a provider of contrast injection systems used to diagnose cardiovascular and other diseases. Possis Medical is a provider of mechanical thrombectomy devices used to treat narrowed or blocked arteries and veins.

Medrad says the combination of the two compatible sales organizations and shared target customer groups establishes an expansive footprint in the cardiovascular intervention field. Medrad’s broad international distribution infrastructure offers a platform for the expansion of Possis Medical’s product portfolio into largely underpenetrated international markets. The companies say the combination of Possis Medical’s thrombectomy platform and Medrad’s vascular injection systems offers a complimentary focus on high-pressure intravascular fluid management and represents a broadened base for future development of new and innovative applications.

Headquartered near Minneapolis, Possis Medical last year posted revenues of $67 million and employs approximately 280 people. Unveiled in 1997, Possis Medical’s AngioJet Rheolytic Thrombectomy System is a leading mechanical thrombectomy system. More than 300,000 patients worldwide have been treated with AngioJet therapy. Possis Medical recently launched the AngioJet Ultra System, a new easier-to-use drive unit.

For more information: www.Medrad.com

Related Content

global thrombectomy devices market, Allied Market Research report, 2022
News | Thrombectomy Devices| January 05, 2017
January 5, 2017 — A new report published by Allied Market Research forecasts that the global...
Neuravi, EmboTrap II stent retriever, thrombectomy device, acute stroke, European launch, CE Mark
News | Thrombectomy Devices| September 28, 2016
Neuravi recently announced Conformité Européenne (CE) Mark approval and launch of the company’s newly available...
Penumbra System, ACE68 Reperfusion Catheter, thrombectomy device, SNIS 2016, acute ischemic stroke patients
Technology | Thrombectomy Devices| July 27, 2016
July 27, 2016 — Penumbra Inc. announced U.S.
Boston Scientific, Fetch 2 aspiration catheter, Class 1 recall
News | Thrombectomy Devices| April 20, 2016
April 20, 2016 — Boston Scientific Corp. announced a U.S.
SITS Open trial, mechanical thrombectomy devices. pREset, stroke treatment
News | Thrombectomy Devices| March 08, 2016
March 8, 2016 — phenox GmbH announced participation in the SITS Open clinical trial, where pREset and pREset LITE ...
thrombus aspiration, STEMI patients, TCT 2015, TOTAL study
Feature | Thrombectomy Devices| October 20, 2015
A pair of studies presented at the 27th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium...
acute ischemic stroke, larger thrombi retrieval, improved neurological recovery, ESC 2015, MR CLEAN trial, sub-study
Feature | Thrombectomy Devices| September 02, 2015
Retrieval of larger thrombi during intra-arterial treatment (IAT) is associated with improved neurological recovery...
STEMI, ultrasound to treat heart attacks, ultrasound to treat STEMI
Feature | Thrombectomy Devices| June 12, 2015
Breakthrough Research Demonstrates Contrast Ultrasound Can be Used as Heart Attack Treatment 
Aspire, thrombectomy, C. Dorn Smith, aspirators, clot, cold leg, removal

Clot in femoral artery caused by atrial fibrillation

News | Thrombectomy Devices| June 11, 2015
C. Dorn Smith, M.D., vascular surgeon in Kingstree, South Carolina, was successful in using a new device to remove...
Overlay Init